ValuEngine Downgrades Protagonist Therapeutics (NASDAQ:PTGX) to Hold

Retrieved on: 2019-05-19 08:11:15

Tags for this article:

Click the tags to see associated articles and topics

ValuEngine Downgrades Protagonist Therapeutics (NASDAQ:PTGX) to Hold. View article details on hiswai:

Excerpt

<div><b>Schonfeld Strategic Advisors</b> LLC purchased a new stake in Protagonist Therapeutics in the first quarter valued at $301,000. Jefferies Group LLC ...</div>

Article found on:

View Original Article